Assessment of Patient Experiences with Respimat® in Everyday Clinical Practice

C Taube, V Bayer, CM Zehendner, A Valipour - Pulmonary Therapy, 2020 - Springer
Introduction Chronic obstructive pulmonary disease (COPD) is a progressive disease
requiring maintenance therapy. According to the Global Initiative for Chronic Obstructive …

Inhaler Operability and Patient Satisfaction Regarding Genuair® and Respimat® Inhalers for Chronic Obstructive Pulmonary Disease: A Randomized Crossover …

H Ohbayashi, S Kudo, M Ishikawa - Pulmonary Therapy, 2017 - Springer
Abstract Introduction Tiotropium via the Respimat® device, once daily, is a common
treatment for patients with chronic obstructive pulmonary disease (COPD). Aclidinium via the …

Assessment of physical functioning and handling of tiotropium/olodaterol Respimat® in patients with COPD in a real-world clinical setting

KO Steinmetz, B Abenhardt, S Pabst… - … Journal of Chronic …, 2019 - Taylor & Francis
Background Patients with chronic obstructive pulmonary disease (COPD) show signs of
reduced physical activity from the early stages of the disease, impacting morbidity and …

COPD patient satisfaction with ipratropium bromide/albuterol delivered via Respimat: a randomized, controlled study

GT Ferguson, M Ghafouri, L Dai… - International Journal of …, 2013 - Taylor & Francis
Background Ipratropium bromide/albuterol Respimat inhaler (CVT-R) was developed as an
environmentally friendly alternative to ipratropium bromide/albuterol metered-dose inhaler …

Effect of Switching Tiotropium HandiHaler® to Respimat® Soft Mist Inhaler in Patients with COPD: The Difference of Adverse Events and Usability Between …

Y Asakura, N Nishimura, K Maezawa… - Journal of aerosol …, 2013 - liebertpub.com
Abstract Background: Recently, tiotropium Respimat® Soft Mist™ Inhaler has been
developed. Respimat is a multidose and propellant-free kit. The aerosol generated from …

Questionnaire on switching from the tiotropium HandiHaler to the Respimat inhaler in patients with chronic obstructive pulmonary disease: changes in handling and …

S Hanada, S Wada, T Ohno, H Sawaguchi… - … journal of chronic …, 2015 - Taylor & Francis
Background Tiotropium (Spiriva) is an inhaled muscarinic antagonist for patients with
chronic obstructive pulmonary disease (COPD), and is available in two forms: the …

Patient perceptions of the re-usable Respimat® Soft Mist™ inhaler in current users and those switching to the device: A real-world, non-interventional COPD study

M Dreher, D Price, A Gardev… - Chronic Respiratory …, 2021 - journals.sagepub.com
The Respimat® Soft Mist™ inhaler (SMI) has recently been improved, with a re-usable
device replacing the disposable version. Certain countries are currently phasing out the …

Physical functioning in patients with chronic obstructive pulmonary disease treated with tiotropium/olodaterol Respimat in routine clinical practice in Italy

M Carone, A Pennisi, M D'Amato, AF Donati, A Ricci… - Pulmonary …, 2020 - Springer
Introduction Clinical studies have shown significant improvements in exercise capacity in
patients with chronic obstructive pulmonary disease (COPD) who are treated with a …

Patients with Obstructive Lung Disease Prefer Respimat® Soft Mist (TM) Inhaler to pMDI

RV Hodder, W Schurmann, P Moroni, M Barczok - Chest, 2004 - journal.chestnet.org
PURPOSE: Respimat® Soft Mist (TM) Inhaler (SMI) is a novel, propellant-free device which
produces a slow-moving, long-lasting aerosol that is easy to inhale and has excellent …

Assessment of patient satisfaction and preference with the Respimat®

A Forster, R Sauer, M Mattiucci-Gühlke… - …, 2020 - thieme-connect.com
Aim: Respimat® reusable is an enhanced version of the Respimat® soft-mist inhaler,
retaining the aerosol characteristics while adding new features such as reusability, an …